ArticleOncoTargets and therapy2015

Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K).

Gianluca Spitaleri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.